ZUMIEZ INC (ZUMZ)

US9898171015 - Common Stock

18.99  -0.01 (-0.05%)

After market: 18.99 0 (0%)

Fundamental Rating

3

Taking everything into account, ZUMZ scores 3 out of 10 in our fundamental rating. ZUMZ was compared to 122 industry peers in the Specialty Retail industry. ZUMZ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ZUMZ is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year ZUMZ has reported negative net income.
ZUMZ had a positive operating cash flow in the past year.
ZUMZ had positive earnings in 4 of the past 5 years.
Of the past 5 years ZUMZ 4 years had a positive operating cash flow.

1.2 Ratios

ZUMZ's Return On Assets of -7.97% is on the low side compared to the rest of the industry. ZUMZ is outperformed by 71.07% of its industry peers.
With a Return On Equity value of -16.68%, ZUMZ perfoms like the industry average, outperforming 40.50% of the companies in the same industry.
Industry RankSector Rank
ROA -7.97%
ROE -16.68%
ROIC N/A
ROA(3y)2.41%
ROA(5y)4.43%
ROE(3y)4.3%
ROE(5y)8.21%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ZUMZ has a Gross Margin (33.14%) which is comparable to the rest of the industry.
ZUMZ's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ZUMZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-1.25%

6

2. Health

2.1 Basic Checks

ZUMZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZUMZ has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ZUMZ has been reduced compared to 5 years ago.
There is no outstanding debt for ZUMZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ZUMZ has an Altman-Z score of 2.24. This is not the best score and indicates that ZUMZ is in the grey zone with still only limited risk for bankruptcy at the moment.
ZUMZ has a Altman-Z score of 2.24. This is comparable to the rest of the industry: ZUMZ outperforms 49.59% of its industry peers.
There is no outstanding debt for ZUMZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.24
ROIC/WACCN/A
WACC10.25%

2.3 Liquidity

ZUMZ has a Current Ratio of 1.81. This is a normal value and indicates that ZUMZ is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.81, ZUMZ is doing good in the industry, outperforming 76.03% of the companies in the same industry.
ZUMZ has a Quick Ratio of 1.81. This is a bad value and indicates that ZUMZ is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ZUMZ (0.93) is better than 75.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 0.93

3

3. Growth

3.1 Past

The earnings per share for ZUMZ have decreased strongly by -176.34% in the last year.
Looking at the last year, ZUMZ shows a decrease in Revenue. The Revenue has decreased by -8.65% in the last year.
ZUMZ shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.20% yearly.
EPS 1Y (TTM)-176.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)-8.65%
Revenue growth 3Y-4.04%
Revenue growth 5Y-2.2%
Sales Q2Q%2.84%

3.2 Future

Based on estimates for the next years, ZUMZ will show a very strong growth in Earnings Per Share. The EPS will grow by 31.18% on average per year.
The Revenue is expected to grow by 2.92% on average over the next years.
EPS Next Y102.59%
EPS Next 2Y50.12%
EPS Next 3Y31.18%
EPS Next 5YN/A
Revenue Next Year2.96%
Revenue Next 2Y3.02%
Revenue Next 3Y2.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZUMZ. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 23.05, which indicates a rather expensive current valuation of ZUMZ.
The rest of the industry has a similar Price/Forward Earnings ratio as ZUMZ.
ZUMZ is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 23.05

4.2 Price Multiples

ZUMZ's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 40.83
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ZUMZ's earnings are expected to grow with 31.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.12%
EPS Next 3Y31.18%

0

5. Dividend

5.1 Amount

ZUMZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZUMIEZ INC

NASDAQ:ZUMZ (12/20/2024, 8:00:02 PM)

After market: 18.99 0 (0%)

18.99

-0.01 (-0.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)N/A N/A
Inst Owners79.11%
Inst Owner Change-1.77%
Ins Owners21.12%
Ins Owner Change-0.16%
Market Cap364.04M
Analysts48.89
Price Target26.01 (36.97%)
Short Float %6.56%
Short Ratio4.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.06%
Min EPS beat(2)25.88%
Max EPS beat(2)88.24%
EPS beat(4)3
Avg EPS beat(4)-149.72%
Min EPS beat(4)-747.36%
Max EPS beat(4)88.24%
EPS beat(8)6
Avg EPS beat(8)-55.02%
EPS beat(12)7
Avg EPS beat(12)-52.4%
EPS beat(16)11
Avg EPS beat(16)125.4%
Revenue beat(2)2
Avg Revenue beat(2)1.73%
Min Revenue beat(2)1.42%
Max Revenue beat(2)2.03%
Revenue beat(4)3
Avg Revenue beat(4)0.73%
Min Revenue beat(4)-0.69%
Max Revenue beat(4)2.03%
Revenue beat(8)6
Avg Revenue beat(8)0.9%
Revenue beat(12)6
Avg Revenue beat(12)-0.52%
Revenue beat(16)8
Avg Revenue beat(16)1.14%
PT rev (1m)0%
PT rev (3m)30.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-84.29%
EPS NY rev (1m)0%
EPS NY rev (3m)304.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.05
P/S 0.41
P/FCF 40.83
P/OCF 15.4
P/B 1.14
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)-2.57
EYN/A
EPS(NY)0.82
Fwd EY4.34%
FCF(TTM)0.47
FCFY2.45%
OCF(TTM)1.23
OCFY6.49%
SpS46.2
BVpS16.68
TBVpS15.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.97%
ROE -16.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.14%
FCFM 1.01%
ROA(3y)2.41%
ROA(5y)4.43%
ROE(3y)4.3%
ROE(5y)8.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-1.25%
F-Score6
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 64.22%
Cap/Sales 1.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 0.93
Altman-Z 2.24
F-Score6
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)92.16%
Cap/Depr(5y)77.65%
Cap/Sales(3y)2.11%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-176.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y102.59%
EPS Next 2Y50.12%
EPS Next 3Y31.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.65%
Revenue growth 3Y-4.04%
Revenue growth 5Y-2.2%
Sales Q2Q%2.84%
Revenue Next Year2.96%
Revenue Next 2Y3.02%
Revenue Next 3Y2.92%
Revenue Next 5YN/A
EBIT growth 1Y-749.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year196.85%
EBIT Next 3Y79.84%
EBIT Next 5YN/A
FCF growth 1Y-76.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.74%
OCF growth 3Y-52.58%
OCF growth 5Y-25.75%